Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: New cues into the human disease?

Neurobiology of Aging

Volumn 27, Issue 11, 2006, Pages 1618-1631

  Carro, Eva ^a   Trejo, Jose Luis ^a   Spuch, Carlos ^a   Bohl, Delphine ^b   Heard, Jean Michel ^b   Torres Aleman, Ignacio ^a  

^a INSTITUTO CAJAL   (Spain)

^b INSTITUT PASTEUR   (France)

Author keywords

Alzheimer's disease; Amyloidosis; Choroid plexus; Dementia; Insulin like growth factor I receptor

Indexed keywords

AMYLOID BETA PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TAU PROTEIN;

ADOLESCENT; ALZHEIMER DISEASE; AMYLOID NEUROPATHY; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOROID PLEXUS; COGNITIVE DEFECT; DEMENTIA; GLIOSIS; MOUSE; NERVE FUNCTION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY;

AGING; ALZHEIMER DISEASE; ANIMALS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CHOROID PLEXUS; EPITHELIAL CELLS; GLYCOGEN SYNTHASE KINASE 3; GREEN FLUORESCENT PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAZE LEARNING; MICE; MICE, INBRED C57BL; MUTATION; PHOSPHORYLATION; RATS; RATS, WISTAR; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 33748438509     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.09.039     Document Type: Article

References (60)

1. Aleman A., Verhaar H.J., de Haan E.H., de Vries W.R., Samson M.M., Drent M.L., et al. Insulin-like growth factor-I and cognitive function in healthy older men. J Clin Endocrinol Metab 84 2 (1999) 471-475
2. Arvat E., Broglio F., and Ghigo E. Insulin-like growth factor I: implications in aging. Drugs Aging 16 1 (2000) 29-40
3. Avila J., Lucas J.J., Perez M., and Hernandez F. Role of tau protein in both physiological and pathological conditions. Physiol Rev 84 2 (2004) 361-384
4. Banks W.A., Robinson S.M., Verma S., and Morley J.E. Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer's disease. Neuroscience 121 2 (2003) 487-492
5. Bondy C.A., and Lee W.H. Patterns of insulin-like growth factor and IGF receptor gene expression in the brain. Functional implications. Ann N Y Acad Sci 692 (1993) 33-43
6. Capsoni S., Ugolini G., Comparini A., Ruberti F., Berardi N., and Cattaneo A. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci USA 97 12 (2000) 6826-6831
7. Carro E., Nunez A., Busiguina S., and Torres-Aleman I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci 20 8 (2000) 2926-2933
8. Carro E., and Torres-Aleman I. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. Eur J Pharmacol 490 1-3 (2004) 127-133
9. Carro E., Trejo J.L., Busiguina S., and Torres-Aleman I. Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci 21 15 (2001) 5678-5684
10. Carro E., Trejo J.L., Gomez-Isla T., LeRoith D., and Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 8 12 (2002) 1390-1397
11. Carro E, Spuch C, Trejo JL, Antequera D, Torres-Aleman I, Choroid plexas megalin is involved in neuroprotection by serum insulin-like growth factor I. J. Neurosci [in press].
12. Carter C.S., Ramsey M.M., and Sonntag W.E. A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan. Trends Genet 18 6 (2002) 295-301
13. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., et al. Natural oligomers of the amyloid-[beta] protein specifically disrupt cognitive function. Nat Neurosci 8 1 (2005) 79-84
14. D'Hooge R., and De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36 1 (2001) 60-90
15. de Pablo F., and de la Rosa E.J. The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors. Trends Neurosci 18 3 (1995) 143-150
16. De Strooper B., Simons M., Multhaup G., Van Leuven F., Beyreuther K., and Dotti C.G. Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. EMBO J 14 20 (1995) 4932-4938
17. DeMattos R.B., Bales K.R., Cummins D.J., Dodart J.C., Paul S.M., and Holtzman D.M. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 98 15 (2001) 8850-8855
18. Desmaris N., Bosch A., Salaun C., Petit C., Prevost M.C., Tordo N., et al. Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. Mol Ther 4 2 (2001) 149-156
19. Fernandez A.M., Kim J.K., Yakar S., Dupont J., Hernandez-Sanchez C., Castle A.L., et al. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev 15 15 (2001) 1926-1934
20. Gasparini L., Netzer W.J., Greengard P., and Xu H. Does insulin dysfunction play a role in Alzheimer's disease?. Trends Pharmacol Sci 23 6 (2002) 288-293
21. Gasparini L., and Xu H. Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci 26 8 (2003) 404-406
22. Golde T.E. Alzheimer disease therapy: can the amyloid cascade be halted?. J Clin Invest 111 1 (2003) 11-18
23. Gravina S.A., Ho L., Eckman C.B., Long K.E., Otvos Jr. L., Younkin L.H., et al. Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem 270 13 (1995) 7013-7016
24. Hammad S.M., Ranganathan S., Loukinova E., Twal W.O., and Argraves W.S. Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide. J Biol Chem 272 30 (1997) 18644-18649
25. Hock Jr. B.J., and Lamb B.T. Transgenic mouse models of Alzheimer's disease. Trends Genet 17 10 (2001) S7-S12
26. Holcomb L.A., Gordon M.N., Jantzen P., Hsiao K., Duff K., and Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet 29 3 (1999) 177-185
27. Hoshi M., Sato M., Matsumoto S., Noguchi A., Yasutake K., Yoshida N., et al. Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta. Proc Natl Acad Sci USA 100 11 (2003) 6370-6375
28. Ikeda S., Allsop D., and Glenner G.G. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody. Lab Invest 60 1 (1989) 113-122
29. Ingelsson M., Fukumoto H., Newell K.L., Growdon J.H., Hedley-Whyte E.T., Frosch M.P., et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62 6 (2004) 925-931
30. Jain S., Golde D.W., Bailey R., and Geffner M.E. Insulin-like growth factor-I resistance. Endocr Rev 19 5 (1998) 625-646
31. Kato H., Faria T.N., Stannard B., Roberts Jr. C.T., and LeRoith D. Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3). J Biol Chem 268 4 (1993) 2655-2661
32. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., and Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 21 2 (2001) 372-381
33. Kelly B.L., Vassar R., and Ferreira A. Beta-amyloid-induced dynamin 1 depletion in hippocammpal neurons: a potential mechanism for early cognitive decline in Alzheimer's disease. J Biol Chem 280 36 (2005) 31746-31753
34. Kirik D., and Bjorklund A. Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors. Trends Neurosci 26 7 (2003) 386-392
35. Kumar-Singh S., Dewachter I., Moechars D., Lubke U., De Jonghe C., Ceuterick C., et al. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol Dis 7 1 (2000) 9-22
36. Lauckner J., Frey P., and Geula C. Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles. Neurobiol Aging 24 6 (2003) 767-776
37. Little C.S., Hammond C.J., MacIntyre A., Balin B.J., and Appelt D.M. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol Aging 25 4 (2004) 419-429
38. Liu S.J., Zhang A.H., Li H.L., Wang Q., Deng H.M., Netzer W.J., et al. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J Neurochem 87 6 (2003) 1333-1344
39. Lupien S.B., Bluhm E.J., and Ishii D.N. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats. J Neurosci Res 74 4 (2003) 512-523
40. Mayeux R. Epidemiology of neurodegeneration. Annu Rev Neurosci 26 (2003) 81-104
41. Miklossy J., Kraftsik R., Pillevuit O., Lepori D., Genton C., and Bosman F.T. Curly fiber and tangle-like inclusions in the ependyma and choroid plexus-a pathogenetic relationship with the cortical Alzheimer-type changes?. J Neuropathol Exp Neurol 57 12 (1998) 1202-1212
42. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11 1 (1984) 47-60
43. Moxham C.P., Duronio V., and Jacobs S. Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. J Biol Chem 264 22 (1989) 13238-13244
44. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39 3 (2003) 409-421
45. Planel E., Miyasaka T., Launey T., Chui D.H., Tanemura K., Sato S., et al. Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J Neurosci 24 10 (2004) 2401-2411
46. Pons S., and Torres-Aleman I. Insulin-like growth factor-I stimulates dephosphorylation of Ikappa b through the serine phosphatase calcineurin (protein phosphatase 2B). J Biol Chem 275 49 (2000) 38620-38625
47. Savonenko A.V., Xu G.M., Price D.L., Borchelt D.R., and Markowska A.L. Normal cognitive behavior in two distinct congenic lines of transgenic mice hyperexpressing mutant APP SWE. Neurobiol Dis 12 3 (2003) 194-211
48. Schubert M., Gautam D., Surjo D., Ueki K., Baudler S., Schubert D., et al. Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci USA 101 9 (2004) 3100-3105
49. Schwab C., Hosokawa M., and McGeer P.L. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp Neurol 188 1 (2004) 52-64
50. Selkoe D.J. Clearing the brain's amyloid cobwebs. Neuron 32 2 (2001) 177-180
51. Serot J.M., Bene M.C., and Faure G.C. Choroid plexus, ageing of the brain, and Alzheimer's disease. Front Biosci 8 (2003) S515-S521
52. Stein T.D., and Johnson J.A. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J Neurosci 22 17 (2002) 7380-7388
53. Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos Jr. L., Eckman C., et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264 5163 (1994) 1336-1340
54. Tham A., Nordberg A., Grissom F.E., Carlsson-Skwirut C., Viitanen M., and Sara V.R. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. J Neural Transm Park Dis Dement Sect 5 3 (1993) 165-176
55. Vaucher E., Aumont N., Pearson D., Rowe W., Poirier J., and Kar S. Amyloid beta peptide levels and its effects on hippocampal acetylcholine release in aged, cognitively-impaired and -unimpaired rats. J Chem Neuroanat 21 4 (2001) 323-329
56. Xie L., Helmerhorst E., Taddei K., Plewright B., Van Bronswijk W., and Martins R. Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci 22 10 (2002) RC221
57. Yakar S., Liu J.L., Stannard B., Butler A., Accili D., Sauer B., et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96 13 (1999) 7324-7329
58. Yao P.J., Zhu M., Pyun E.I., Brooks A.I., Therianos S., Meyers V.E., et al. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol Dis 12 2 (2003) 97-109
59. Younkin S.G. Amyloid beta vaccination: reduced plaques and improved cognition. Nat Med 7 1 (2001) 18-19
60. Zufferey R., Nagy D., Mandel R.J., Naldini L., and Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15 9 (1997) 871-875